Bharat Biotech

AIIMS Delhi To Begin Covaxin Trials On Children Today Amid Third Wave Scare

Clinical trial of Bharat Biotech's vaccine on children to start from tomorrow in Delhi AIIMS

Biological E’s Corbevax At Rs 250/Dose May Be Cheapest Covid-19 Vaccine In India

'More Info Required': WHO To Bharat Biotech As It Submits ‘90% Documents’ For Emergency Use Listing Of Covaxin

Corona Crisis: Trial of 3rd dose of Covaxin begins in AIIMS

16 companies are capable of manufacturing Covaxin; why we aren't producing 25 crore vaccine doses: Kejriwal

'Why Is Centre Preventing Bharat Biotech From Sharing Vaccine Formula If They Are Ready?': CM Kejriwal

Clinical trial of third dose of Covaxin to start soon

Delhi HC Refuses to Stay Covaxin Clinical Trial On Children; Issues Notice to Centre, DGCI

Covaxin Effective Against Covid Variants Found In India & UK: Bharat Biotech

Covid third wave: A look at preparation of Centre & State Govts

Will Bharat Biotech's 'Nasal Vaccine' Become Game-Changer For India?